Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Women's cancers in the Democratic Republic of Congo
Prof Richard Sullivan - Kings College London, London, UK
Women's cancers in the Democratic Republic of Congo ( Prof Richard Sullivan - Kings College London, London, UK )
12 May 2021
Rare inherited pathogenic germline variants observed in sporadic paediatric neur...
Dr Emily Blauel - Children’s Hospital of Philadelphia, Philadelphia, USA
Rare inherited pathogenic germline variants observed in sporadic paediatric neuroblastoma cases ( Dr Emily Blauel - Children’s Hospital of Philadelphia, Philadelphia, USA )
11 May 2021
Psycho-oncology service provisions for hospitalised cancer patients before and d...
Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India
Psycho-oncology service provisions for hospitalised cancer patients before and during the COVID19 pandemic ( Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India )
10 May 2021
OncoAlert and ecancer weekly roundup for April 26 - May 3, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for April 26 - May 3, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
7 May 2021
UpSwinG: Real-world, non-interventional cohort study on TKI activity in patients...
Dr Satoru Miura - Niigata Cancer Center Hospital, Niigata, Japan
UpSwinG: Real-world, non-interventional cohort study on TKI activity in patients with EGFRm  NSCLC with uncommon mutations ( Dr Satoru Miura - Niigata Cancer Center Hospital, Niigata, Japan )
4 May 2021
PIPSeN trial: Olaparib maintenance vs placebo in platinum-sensitive non-small ce...
Dr Sophie Postel-Vinay - Gustave Roussey Cancer Center, Paris, France
PIPSeN trial: Olaparib maintenance vs placebo in platinum-sensitive non-small cell lung cancer ( Dr Sophie Postel-Vinay - Gustave Roussey Cancer Center, Paris, France )
4 May 2021
Efficacy and early discontinuation predictors in NSCLC patients receiving nivolu...
Dr Giulia Pasello - University of Padova, Padua, Italy
Efficacy and early discontinuation predictors in NSCLC patients receiving nivolumab ( Dr Giulia Pasello - University of Padova, Padua, Italy )
4 May 2021
MRTX9768: a synthetic lethal-based inhibitor designed to bind the PRMT5 MTA comp...
Dr Matthew Marx - Mirati Therapeutics, San Diego, USA
MRTX9768: a synthetic lethal-based inhibitor designed to bind the PRMT5 MTA complex and target MTAP/CDKN2A-deleted tumours ( Dr Matthew Marx - Mirati Therapeutics, San Diego, USA )
30 Apr 2021
Palliative Care: Industry and Academia – Tensions and Opportunities
Dr Jim Cleary - IU Simon Cancer Center, Indianapolis, USA
Palliative Care: Industry and Academia – Tensions and Opportunities ( Dr Jim Cleary - IU Simon Cancer Center, Indianapolis, USA )
29 Apr 2021
Anti-tumour activity and tolerability of RMC-4630 as a single agent in patients ...
Prof Ravi Salgia - City of Hope, Duarte, USA
Anti-tumour activity and tolerability of RMC-4630 as a single agent in patients with RAS-addicted solid cancers ( Prof Ravi Salgia - City of Hope, Duarte, USA )
26 Apr 2021
Mechanisms of acquired resistance to KRAS G12C inhibition in cancer
Dr Mark Awad - Dana-Farber Cancer Institute, Boston, USA
Mechanisms of acquired resistance to KRAS G12C inhibition in cancer ( Dr Mark Awad - Dana-Farber Cancer Institute, Boston, USA )
26 Apr 2021
OncoAlert and ecancer weekly roundup for April 19 - 25, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for April 19 - 25, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
26 Apr 2021